Keratinocyte growth factor: Not yet ready for prime time

Journal of Clinical Oncology

Volumn 21, Issue 8, 2003, Pages 1429-1430

  Loprinzi, Charles L ^a   Martenson, James A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FGF7 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; RECOMBINANT PROTEIN;

CLINICAL TRIAL; DRUG EFFECT; HUMAN; MUCOSA; NOTE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; HUMANS; MUCOUS MEMBRANE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0037842186     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.02.041     Document Type: Editorial

References (19)

1. Meropol NJ, Somer RA, Gutheil J, et al: Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant. J Clin Oncol 21:1452-1458, 2003
2. Barsky AJ, Saintfort R, Rogers MP, et al: Nonspecific medication side effects and the nocebo phenomenon. J Am Med Assoc 287:622-627, 2002
3. Mahood DJ, Dose AM, Loprinzi CL, et al: Inhibition of fluorouracilinduced stomatitis by oral cryotherapy. J Clin Oncol 9:449-452, 1991
4. Loprinzi CL, Cianflone SG, Dose AM, et al: A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 65:1879-1882, 1990
5. Rocke LK, Loprinzi CL, Lee JK, et al: A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracilrelated stomatitis. Cancer 72:2234-2238, 1993
6. Foote RL, Loprinzi CL, Frank AR, et al: Randomized trial of chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 12:2630-2633, 1994
7. Fidler P, Loprinzi CL, O'Fallon JR, et al: Prospective trial of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 77:522-525, 1996
8. Martenson JA, Bollinger JW, Sloan JA, et al: Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III doubleblind placebo-controlled trial. J Clin Oncol 18:1239-1245, 2000
9. McGinnis WL, Loprinzi CL, Buskirk SJ, et al: Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol 15:1239-1243, 1997
10. Kozelsky TF, Meyers GE, Sloan JA, et al: Ten phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol 21:xxx-xxx, 2003
11. Watkins-Bruner D, Scott C, Lawton C, et al: RTOG's first quality of life study: RTOG 90-20 - A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 33:901-906, 1995
12. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
13. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
14. Kollmorgen CF, Meagher AP, Wolff BG, et al: The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 220:676-682, 1994
15. Tveit KM, Guldvog I, Hagen S, et al: Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer: Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84:1130-1135, 1997
16. Dahlberg M, Glimelius B, Graf W, et al: Preoperative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum 41:543-551, 1998
17. Lundby L, Jensen VJ, Overgaard J, et al: Long-term colorectal function after postoperative radiotherapy for colorectal cancer. Lancet 350:564, 1997
18. Cascinu S, Fedli A, Fedli SL, et al: Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer, Part B: Oral Oncol 30B:234-236, 1994
19. Clarkson JE, Worthington HV, Eden OB. Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). Cochrane Database Syst Rev 2:CD000978, 2000